IFOM and A*STAR enter 'alliance without boundaries' for cancer research

The Italian FIRC Institute of Molecular Oncology (IFOM) and the Agency for Science and Technology of Singapore (A*STAR) earlier this month announced the launch of the IFOM-p53Lab Joint Research Laboratory for cancer research in Singapore.

The activities of the IFOM-p53Lab Joint Research Laboratory will focus on new targeted therapies against cancer. They will leverage the combined knowledge and technological expertise of the two agencies to accelerate the transfer of scientific findings from the laboratory to clinical practice.

IFOM strongly believes that the future of cancer research relies on the establishment of international cooperative agreements to achieve the necessary synergies and benefits resulting from shared technologies, human resources and cross-fertilization of ideas. Established by the Italian Foundation for Cancer Research (FIRC), IFOM is a private Italian institute dedicated to the study of tumor formation and development. After 10 years of scientific activity, IFOM is actively developing a network of partnerships with highly competitive international players in Asia.